肺多形性癌的肿瘤异质性溯源
研究对20例肺多形性癌(PPC)患者的42个肿瘤区域(39个原发灶和3个转移灶)进行显微切割和全外显子组测序,并对14例患者的28个样本进行RNA测序和甲基化数据的计算机分析。结果显示上皮和肉瘤样成分共享大量基因组改变,多数驱动基因突变为克隆性主干突变,提示共同祖先;RTK-RAS通路改变频繁。转移灶形态和遗传上类似上皮或肉瘤样成分。肉瘤样成分的转录组和表观遗传谱与配对上皮成分更相似。NCAM1/CD56在鳞状样PPC的肉瘤样成分中优先表达,而CDH1/E-Cadherin在多数PPC的肉瘤样成分中下调。结论认为肺腺癌样PPC主要由RTK-RAS信号驱动,而上皮-间质转化程序(NCAM1升高、CDH1降低)主导克隆相关肿瘤成分间的上皮-肉瘤样转化。
要点
- PPC上皮与肉瘤样成分共享多数驱动基因的克隆性主干突变,提示共同祖先。
- RTK-RAS通路改变频繁,可能在PPC演化中起重要作用。
- 肉瘤样成分转录组和表观遗传谱更接近配对上皮成分;NCAM1在鳞状样PPC肉瘤样成分优先表达,CDH1在多数PPC肉瘤样成分下调。
核心结论
- 肺腺癌样PPC主要由RTK-RAS信号驱动,上皮-间质转化程序(NCAM1升高、CDH1降低)主导克隆相关成分间的上皮-肉瘤样转化。
- PPC中的若干改变指出了治疗机会。
研究设计与样本
- 对20例PPC患者的42个肿瘤区域(39个原发灶和3个转移灶)进行显微切割,对组织学不同成分分别行全外显子组测序。
- 对14例PPC患者的28个样本的显微切割bulk RNA测序和甲基化数据进行计算机分析。
- 使用免疫组化验证发现。
主要发现
- PPC的上皮和肉瘤样成分共享大量基因组改变。
- 多数癌症驱动基因突变为两个成分间的克隆性主干突变,提示共同祖先。
- RTK-RAS通路改变数量高,提示其在PPC演化中起重要作用。
- 转移灶形态和遗传上类似肿瘤的上皮或肉瘤样成分。
- 具有匹配鳞状样或腺癌样成分的PPC肉瘤样成分的转录组和表观遗传谱彼此不同,且与各自匹配的上皮成分更相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Pulmonary pleomorphic carcinoma (PPC) is an aggressive and highly heterogeneous NSCLC whose underlying biology is still poorly understood. METHODS: A total of 42 tumor areas from 20 patients with PPC were microdissected, including 39 primary tumors and three metastases, and the histologically distinct components were subjected to whole exome sequencing separately. We further performed in silico analysis of microdissected bulk RNA sequencing and methylation data of 28 samples from 14 patients with PPC. We validated our findings using immunohistochemistry. RESULTS: The epithelial and the sarcomatoid components of PPCs shared a large number of genomic alterations. Most mutations in cancer driver genes were clonal and truncal between the two components of PPCs suggesting a common ancestor. The high number of alterations in the RTK-RAS pathway suggests that it plays an important role in the evolution of PPC. The metastases morphologically and genetically resembled the epithelial or the sarcomatoid components of the tumor. The transcriptomic and epigenetic profiles of the sarcomatoid components of PPCs with matched squamous-like or adenocarcinoma-like components differed from each other, and they shared more similarities to their matched epithelial components. NCAM1/CD56 was preferentially expressed in the sarcomatoid component of squamous-like PPCs, whereas CDH1/E-Cadherin expression was down-regulated in the sarcomatoid component of most PPCs. CONCLUSION: Lung adenocarcinoma-like PPCs are mainly driven by RTK-RAS signaling, whereas epithelial-mesenchymal transition programs as highlighted by increased NCAM1 and decreased CDH1 expression govern the epithelial-sarcomatoid transition between the clonally related tumor components. Several alterations in PPCs pinpoint therapeutic opportunities.
引用
- Roma L, Ercan C, Conticelli F, et al. Tracing Tumor Heterogeneity of Pleomorphic Carcinoma of the Lung. J Thorac Oncol. 2024. PMID: 38723776. doi:10.1016/j.jtho.2024.04.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。